Sanofi (SNW2) — Cash Flow Reinvestment Rate
Sanofi (SNW2) has a Cash Flow Reinvestment Rate of 2.41x as of September 2025, reinvesting €9.04 Billion (capex €0.00 plus investments €-9.04 Billion) from operating cash flow of €3.75 Billion. See Sanofi free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sanofi Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Sanofi across 9 annual periods. For the full cash flow conversion analysis, see Sanofi cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Sanofi (2016–2024)
Year-by-year capital reinvestment analysis for Sanofi. See SNW2 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | €7.60 Billion | €9.08 Billion | €3.19 Billion | ▼ -6.9% |
| 2023 | 0.90x | €9.22 Billion | €10.26 Billion | €3.02 Billion | ▲ +382.9% |
| 2022 | 0.19x | €1.96 Billion | €10.53 Billion | €1.61 Billion | ▲ +12.1% |
| 2021 | 0.17x | €1.75 Billion | €10.52 Billion | €1.48 Billion | ▼ -89.3% |
| 2020 | 1.55x | €11.49 Billion | €7.42 Billion | €1.25 Billion | ▲ +777.8% |
| 2019 | 0.18x | €1.36 Billion | €7.71 Billion | €1.32 Billion | ▼ -36.9% |
| 2018 | 0.28x | €1.55 Billion | €5.55 Billion | €1.42 Billion | ▲ +42.5% |
| 2017 | 0.20x | €1.45 Billion | €7.38 Billion | €1.39 Billion | ▼ -66.5% |
| 2016 | 0.59x | €4.59 Billion | €7.84 Billion | €2.08 Billion | — |